Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES（2024）
Key words
multiple sclerosis,B cells,disease modifying treatments,ocrelizumab,extended dosing,immunoglobulins
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined